Fibrinogen-to-albumin ratio: a new biomarker to identify inflammatory bowel disease in active stage

Fibrinogen-to-albumin ratio: a new biomarker to identify inflammatory bowel disease in active stage

IntroductionThe objective of our study was to externally validate the value of the fibrinogen-to-albumin ratio (FAR), a new biomarker used to identify active inflammatory bowel disease (IBD).Materials and methodsA total of 245 ulcerative colitis (UC) and 543 Crohn’s disease (CD) patients were includ...

Full description

Bibliographic Details
Main Authors: Xiao-Fu Chen, Zhi-Ming Huang, Xie-Lin Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Medicine
Subjects:
albumin
biomarker
fibrinogen
inflammatory bowel disease
activity
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1460975/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1460975/full

Similar Items